RankAlpha logo
Back to Rankings

ATR

AptarGroupB
NYSE / Materials
Last Price
Quote time unavailable
View Chart
Current thesis
The Q2 EPS beat, sales growth across all segments, explicit Q3 EPS guidance of $1.45-$1.53 and Pharma demand tied to injectables, biologics and GLP-1 therapies support a cautiously improving operating thesis. [#SEC-8K-2026-07-30]
Posture
Constructive
Lead driver
Sentiment
What changed
Next scheduled catalyst: earnings 2026-10-29 · AMC.
What can break
Adjusted EBITDA margin declined to 20.7% from 22.6% year over year, with Beauty and Closures exposed to mix and operational pressure. [#SEC-8K-2026-07-30]
Momentum
56
Value
54
Sentiment
68
Setup hits (3d)
0 · Net Neutral
AI TargetsBase $150.00 · Bull $171.17 · Bear $120.00Analysis 2026-08-04; returns require an exact persisted reference.
Earnings
2026-10-29 · AMC
Data freshness
Prices
Unavailable: Price unavailable
Fundamentals
As of 2026-10-26 • Vendor: Data Vendor v1
Scores
As of 2026-10-23 • Model: HYBRID_IC_RP
AI Memo
As of 2026-08-04 • Model: RankAlpha Sentiment Codex
Investment thesis
As of 2026-10-23

Grade is the composite factor band; factor scores use a 0–100 scale. Confidence describes evidence quality, not a probability of return. Score date: 2026-10-23. Definitions

Supporting evidence
What
Grade B · Constructive
Confidence Medium · Net Neutral
Target $162.00
Why
Momentum56 · Δ7d -1.6
Value54 · Δ7d -0.3
Sentiment68 · Δ7d -2.2
So what
Strength-led posture (Net Neutral). Favor watchlist adds and disciplined entries.

Confirming evidence

  • • Next scheduled catalyst: earnings 2026-10-29 · AMC.
  • • Sentiment remains the lead driver in the composite, 7D delta -2.2.

Contradictions & invalidation

  • • Adjusted EBITDA margin declined to 20.7% from 22.6% year over year, with Beauty and Closures exposed to mix and operational pressure. [#SEC-8K-2026-07-30]
  • • CEO succession on September 1, 2026 creates a continuity and execution monitoring point. [#EARNINGS-TRANSCRIPT-2026Q2]
  • • Near-term earnings quality is constrained by emergency-medicine destocking, lower adjusted EBITDA margin, Beauty and Closures execution issues, and the upcoming CEO transition.

Catalyst clock

2026-10-29 · AMC

Q2 earnings beat with explicit Q3 guidance

Lead driver: Sentiment · See AI snapshot
Momentum
56
8% active weight
Current posture
7d trendSoftening
Δ7d
-1.6
Δ21d
+1.5
Value
54
47% active weight
Current posture
7d trendFlat
Δ7d
-0.3
Δ21d
-1.1
Sentiment
68
45% active weight
Current posture
7d trendSoftening
Δ7d
-2.2
Δ21d
-17.1
Why this grade

Composite grade B. Momentum 55.8 / Value 53.8 / Sentiment 67.8

Scenario snapshot

Scenario probability is memo-authored likelihood, not forecast certainty. Targets belong to the analysis dated 2026-08-04. Scenario method

B+
Bull case
25%
Probability
Target price
$171.17
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Most likely
B
Base case
50%
Probability
Target price
$150.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
B-
Bear case
25%
Probability
Target price
$120.00
Analysis reference price unavailable
Analysis 2026-08-04 · RankAlpha Sentiment Codex
Fundamentals (TTM)
As of 2026-10-26
Market Cap
$8.08B
Beta
0.48
Shares Out
63.58M
P/E (TTM)
19.7
P/S (TTM)
2.20
P/FCF (TTM)
43.19
Rev YoY
+6.3%
EPS YoY
-18.1%
Gross Margin
+28.3%
Op Margin
+12.4%
Net Debt
$1.14B
Current Ratio
1.61
As of 2026-10-23 • Updated nightlySource: Internal modelMethods & Data